DOI:
10.1055/s-00000002
Aktuelle Dermatologie
LinksClose Window
References
Tawbi HA, Forsyth PA, Hodi FS. et al.
Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204).
Journal of Clinical Oncology 2019;
37: 9501
DOI: 10.1200/JCO.2019.37.15_suppl.9501.
We do not assume any responsibility for the contents of the web pages of other providers.